Tectonic Therapeutic (TECX) traded down -4.84 % during a 24 hours period ending at 04:19 PM Central Europe on Monday 26th. One Tectonic Therapeutic stock can currently be bought for about USD 20.2 on popular exchanges. Current supply of Tectonic Therapeutic stocks is 19.5 mn. Tectonic Therapeutic has a current market capitalization of USD 392.4 mn and approximately USD 2.9 mn worth of Tectonic Therapeutic was traded on exchanges in the last 24 hours. Since last month end, Tectonic Therapeutic has traded -16.79 % down. Simple moving average of last 200 days is at USD 28.08. The highest price of past 52 weeks was recorded at USD 39.53 on 07/06/2026. 52 weeks low was at USD 15.52 on 11/05/2025.
Here is how related stocks have performed in the past 24 hours:
Phathom (PHAT) traded down -18.12 % and now trades at USD 5.91. Phathom has a market capitalisation of USD 464.4 mn.
Verra Mobility (VRRM) traded down -1.59 % and now trades at USD 3.08. Current market capitalisation for Verra Mobility is USD 469.6 mn. Current price/earnings ratio for Verra Mobility is 10.79.
Ramaco (METC) traded up 1.24 % and now trades at USD 7.19. Ramaco has a market capitalisation of USD 466.2 mn.
Cerus (CERS) traded up 0.87 % and now trades at USD 2.41. Current market capitalisation for Cerus is USD 469.6 mn.
Diamedica Therapeutics (DMAC) traded up 1.04 % and now trades at USD 8.81. Diamedica Therapeutics has a market capitalisation of USD 470.2 mn.
About Tectonic Therapeutic
Avrobio Inc. is a clinical-stage biotechnology company based in Cambridge, Massachusetts, USA. The company specializes in developing single-dose gene therapies targeted towards resisting and reversing fabry, Gaucher, cystinosis, and pompe diseases. As a global player, Avrobio serves its customers worldwide. You can find more information about their activities and offerings on their website www.avrobio.com or through trading on the Nasdaq stock exchange.